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TO THE EDITOR 
 Niemann-Pick disease type C (MIM 607625; NP-C) is an autosomal recessive, lysosomal 









variations in either NPC1 (accounting for more than 95% of cases) or NPC2 [Park et al., 2003]. 
The birth incidence ranges from 0.66 and 0.83 per 100,000 in France, the United Kingdom, and 
Germany. However, this disorder is observed less frequently in Australia, the Netherlands, and 
Northern Portugal [Vanier 2010]. Niemann-Pick disease type C is a clinically heterogeneous 
multisystem disorder leading to accumulation of fat and neurodegeneration. Being a 
neurovisceral disorder, it mainly affects liver, spleen, lungs, and nervous system [Patterson et 
al., 2012]. Here we report the first patient with NP-C associated with a deletion of two exons in 
NPC2. 
 The proband was an only child, born at term to a non-consanguineous couple of Asian 
origin. Her BW was 3.5 kg, normal. She was evaluated at three months of age for failure to 
thrive, cough, and loose stools. She was treated symptomatically for cough. However, she 
continued to have these symptoms requiring a hospital admission at five months of age for 
further evaluation. There was delay in motor development and she could not hold her neck or 
roll over at age 5 months.  
 Examination at 5 months of age showed generalized lymphadenopathy. She also had 
hepatosplenomegaly (spleen palpable 6 cm below the costal margin and liver 4 cm below the 
costal margin), consistent with abdominal ultrasonographic findings. She weighed 4.7 kg (<3
rd
 
centile), her OFC was 38 cm (more than -4 SD) and length was 68 cm (normal). Complete blood 
count and liver functions were unremarkable. The toxoplasma, cytomegalovirus, rubella, and 
herpes simplex IgM serologies were negative. The tests for hepatitis B surface antigen and 
human immunodeficiency virus were negative. Fat globules were absent in the stool. Lipid 









Bone marrow aspiration showed hematopoietic cells and scattered large foamy histiocytes 
having finely, vacuolated cytoplasm which were negative for Periodic Acid Schiff reagent, 
suggestive of Nieman-Pick disease (Figure 1). Several attempts to assay sphingomyelinase levels 
in leukcocytes (for Neimann-Pick disease Type A) failed due to degraded samples. No mutations 
were identified on Sanger sequencing of SMPD1. At age of 8 months she succumbed to death 
due to respiratory failure. .. 
Genomic DNA was extracted from the preserved whole blood of the child and parents 
using the standard phenol-chloroform method. Massively parallel sequencing of the exome was 
done using the NextSeq500 Sequencer (Illumina Inc., San Diego, CA, USA) in combination with 
the NextSeq™ 500 High Output Kit (2x150bp). These methods have been described in detail 
[Girisha et al., 2016]. 
 To our surprise, none of the genes known to cause a storage disorder had a strong 
candidate variant. Based on the convincing clinical suspicion and the suggestion of a storage 
disease by foamy histiocytes, the genes known to cause storage disorders were analyzed on 
IGV. There were no reads for exon 2 and exon 3 of NPC2 in the proband, whereas, the parents 
presented only half of the coverage expected for both the exons on healthy individuals (Figure 
2). To validate the deletion of these two exons, multiplex ligation-dependent probe 
amplification (MLPA) was performed, which confirmed the homozygous deletion of exons 2 and 
3 of NPC2 in the proband and heterozygous carrier status for the same in both the parents 
(Figure 3). We inspected the entire exome dataset for the family and both the kinship 
coefficient and the homozygous variants distribution in the proband evidence that this is likely 









despite the parents denying obvious consanguinity in our earlier work [Bidchol et al., 2014; 
Bidchol et al., 2015; Dalal et al., 2012]. 
 The current patient portrays the clinical course of an early infantile onset group of NP-C, 
classified based on the age of onset, neurological manifestations and foamy histiocytes in bone 
marrow. In this group, the hepatosplenomegaly is the predominant visceral sign as observed in 
here [Alobaidy 2015]. The cough and respiratory failure in the proband can be attributed to 
infiltration of the lungs with foam cells due to impaired diffusion [Patterson et al., 2012]. 
Pulmonary insufficiency leading to respiratory failure has been reported in infants with NP-C2 
[Millat et al., 2001; Reunert et al., 2015]. Recently, a new screening approach to diagnose NP-C 
by detecting the elevated oxysterols was proposed by Griese et al [2010]. The NPC2 protein is a 
glycoprotein coded by the 5 exons of NPC2 gene. Although the exact functions of NPC1 and 
NPC2 genes remain obscure, they are believed to function in a synchronized fashion in the 
cellular post lysosomal/late endosomal transport of cholesterol and other molecules [Sleat et 
al., 2004].  
NPC2 gene mutations were first described in two families by Naureckiene et al. [2000] 
where they found one homozygous variant, c.58G>T and compound heterozygous variants 
c.58G>T and c.332delA, respectively. A study of eight unrelated families from France, Algeria, 
Italy, Germany, the Czech Republic, and Turkey identified two nonsense variants (p.(Glu20Ter), 
p.(Glu118Ter)), one missense variant (p.(Ser67Pro)), one splice site mutation (c.190+5 G>A), 
and one single base pair deletion (c.27delG) [Millat et al., 2001]. Thirteen more 
missense/nonsense variants were reported by Chikh et al [2005]. Currently, 25 disease-causing 









three splice site changes and three small deletions. Deletions of an entire exon have not been 
reported. We could not determine the breakpoints and size of the deleted region or study the 
transcript in this patient. It is necessary to emphasize here that these whole exonic deletions 
when present in a compound heterozygous state, would not be detected by exome sequencing 
unless specifically tested for copy number variations.  
 Here we report the first patient with NPC-2 due to a homozygous deletion of two exons 
in the NPC2 gene.  
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Supplemental online Figure Legends 
Supplemental Figure 1 online : A. Bone marrow aspiration shows large foamy histiocytes with 
vacuolated cytoplasm (Leishman stain; x40) B. A typical storage cell with finely vacuolated 
cytoplasm (Leishman stain; x100). 
Supplemental Figure 2 online: Exome sequencing of the trio followed by alignment of paired-
end reads (gray horizontal bars) to the human genome assembly 37 (hg19) showed no reads for 
exon 2 and exon 3 of NPC2 gene in the proband (red arrows). Parents had reduced coverage for 
both the exons (proband-upper panel, mother-middle panel, father-lower panel). 
Supplemental Figure 3 online: Multiplex ligation-dependent probe amplification using the 
SALSA MLPA probe sets P193 identified a homozygous deletion of exon 2 and 3 in the proband 
(blue bars: control, green bars: test) and heterozygous carrier status for the same in both the 

































Figure 3  . 
 
